INMEDIX

inmedix-logo

Inmedix has discovered and is commercializing a novel class of diagnostics and therapeutics. Their approach focuses on autonomic nervous system (ANS) control of stress responses within the brain. In the setting of an autoimmune disease, ANS stress can significantly intensify an autoimmune disease. They call it Immuno-autonomics. They seek to understand and block this process to allow current autoimmune disease therapies to work much better.

#SimilarOrganizations #People #Website #More

INMEDIX

Industry:
Biotechnology Health Care Therapeutics

Founded:
2006-01-01

Address:
Seattle, Washington, United States

Country:
United States

Website Url:
http://www.inmedix.com

Status:
Active

Contact:
206-412-5347

Email Addresses:
[email protected]

Total Funding:
470 K USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Nginx Microsoft Exchange Online


Similar Organizations

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

Current Employees Featured

andrew-j-holman_image

Andrew J Holman
Andrew J Holman CEO & Co-founder @ Inmedix
CEO & Co-founder
2006-06-01

Founder


andrew-j-holman_image

Andrew J Holman

Official Site Inspections

http://www.inmedix.com

  • Host name: 172.67.203.100
  • IP address: 172.67.203.100
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Inmedix"

About - inmedix.com

History and Mission Inmedix LLC was founded in 2006 by Andrew J Holman, MD, and Mr. Timothy Sciarrillo as a patent holding company for Dr. Holmanโ€™s discoveries. Its first project โ€ฆSee details»

Inmedix - Crunchbase Company Profile & Funding

Inmedix brings cloud-based clinical diagnostics and immuno-autonomics to medicine to improve outcomes in autoimmune diseases and beyond.See details»

Inmedix Inc - LinkedIn

Inmedix Inc Biotechnology Research Normandy Park, WA 162 followers Bringing accurate and safe HRV meeting FDA standards to clinicians.See details»

Inmedix - 2025 Company Profile & Team - Tracxn

Aug 2, 2025 Inmedix is a seed company based in Burien (United States), founded in 2006 by Andrew J Holman and Timothy Sciarrillo. It operates as a Developer of the device for โ€ฆSee details»

Inmedix 2025 Company Profile: Valuation, Funding

Information on valuation, funding, cap tables, investors, and executives for Inmedix. Use the PitchBook Platform to explore the full profile.See details»

Inmedix - Overview, News & Similar companies | ZoomInfo.com

Jan 3, 2024 View Inmedix (www.inmedix.com) location in Washington, United States , revenue, industry and description. Find related and similar companies as well as employees by title and โ€ฆSee details»

Inmedix Company Profile - Office Locations, Competitors ... - Craft

Inmedix has 1 employees at their 1 location. See insights on Inmedix including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

Home [inmedix.com]

Featured Research What is the science behind immuno-autonomics? Click on the new educational animation from Inmedix and Random42, London.See details»

Inmedix - Products, Competitors, Financials, Employees, โ€ฆ

About Inmedix Inmedix provides medical diagnostics and research within the healthcare sector. The company specializes in developing a point-of-service diagnostic tool that utilizes heart rate โ€ฆSee details»

Inmedix, LLC | EquityNet

Inmedix, a boutique biotech company, is now working on commercializing its second major patent. The first patent was acquired by a large pharmaceutical company at an historic valuation. โ€ฆSee details»

Inmedix - Leadership Team | The Org

The Leadership Team at Inmedix drives the strategic direction and operational oversight of the company, leveraging their diverse expertise in technology and medicine to advance cloud โ€ฆSee details»

Inmedix Inc - LinkedIn

Inmedix is working to bring a point-of-service diagnostic to medicine applying heart rate variability (HRV) on a high fidelity ECG platform with analysis and reporting from the cloud. We are โ€ฆSee details»

Company Overview - inmedix.com

Inmedix is laser focused on understanding the ANS and aspires to discerning its role in human physiology and illness. Discovery is difficult, but we believe it's more than possible and we're โ€ฆSee details»

Keiretsu Forum | Inmedix Named "Most Valued Company" at โ€ฆ

Apr 4, 2025 Inmedix, a leader in the field of stress-related immune dysfunction research, has been voted as the "Most Valued Company" at the Keiretsu Forum Investor Capital Expo held โ€ฆSee details»

Inmedix - Funding, Financials, Valuation & Investors

Inmedix brings cloud-based clinical diagnostics and immuno-autonomics to medicine to improve outcomes in autoimmune diseases and beyond.See details»

Our Team - inmedix.com

Management and Advisory Board Inmedix team members bring decades of combined experience within life sciences management in diagnostic, regulatory, engineering, commercialization, โ€ฆSee details»

Inmedix Recognized as the #1 โ€˜Most Valued Companyโ€™ at the โ€ฆ

Apr 6, 2025 Voted by angel investors as a stand-out innovator amongst a group of highly touted, growth-stage entrepreneurial companies from the U.S. and Canada NORMANDY PARK , WA, โ€ฆSee details»

Inmedix | Inmedix, Innovative Medical Discovery

Inmedix conducts leading research to help those with autoimmune diseases get their life back.See details»

Inmedix completes $4M bridge convertible note round with angel ...

Inmedix completes $4M bridge convertible note round with angel investors to develop and commercialize medical-grade HRV Proceeds to fund final engineering, cloud processing and โ€ฆSee details»

Inmedix again a Keiretsu Expo Most Valued Company in 2021

Inmedix conducts leading research to help those with autoimmune diseases get their life back.See details»

linkstock.net © 2022. All rights reserved